Elisa Genuardi

14PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Jun 25, 2026
Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma.

|Jan 30, 2026
Evaluation of the Role of AID-Induced Mutagenesis in Resistance to B-Cell Receptor Pathway Inhibitors in Chronic Lymphocytic Leukemia.

Chiara Pighi, Alessandro Gasparetto, Elisa Genuardi

|Jan 14, 2025
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial.

Simone Ragaini, Anna Galli, Elisa Genuardi

|Apr 14, 2023
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.

Simone Ferrero, Daniele Grimaldi, Elena Arrigoni

|Feb 02, 2023
Looking for a needle in the haystack of CLL.

Simone Ferrero, Elisa Genuardi

Pageof 3

Frequent Collaborators

9 joint publications

Simone Ferrero

4 joint publications

Daniela Drandi

3 joint publications

Gian Maria Zaccaria

3 joint publications

Monica Balzarotti